Gene · 4192
Papers2,993
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,993
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Oncology of Bladder Cancer from Inception to Modern Perspective. | Cancers (Basel) | 2022 | 35681556 | PubTator, text mining | PubMed |
| Clinical Value and Molecular Function of Circulating MicroRNAs in Endometrial Cancer Regulation: A Systematic Review. | Cells | 2022 | 35681531 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the characteristics of cerebrospinal fluid tumour environment in breast cancer and lung cancer leptomeningeal metastases. | Clin Transl Med | 2022 | 35678121 | PubTator, text mining | PubMed |
| Characterization of the Estrogen Response Helps to Predict Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma. | Front Oncol | 2022 | 35664769 | PubTator, text mining | PubMed |
| The Role of Growth Factors in the Repair of Motor Injury. | Front Pharmacol | 2022 | 35662720 | PubTator, text mining | PubMed |
| Phospholipid scramblase 1: a protein with multiple functions via multiple molecular interactors. | Cell Commun Signal | 2022 | 35650588 | PubTator, text mining | PubMed |
| Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases. | Med | 2022 | 35649411 | PubTator, text mining | PubMed |
| Applications of Proteomics in Ovarian Cancer: Dawn of a New Era. | Proteomes | 2022 | 35645374 | PubTator, text mining | PubMed |
| Pleiotrophin Interaction with Synthetic Glycosaminoglycan Mimetics. | Pharmaceuticals (Basel) | 2022 | 35631323 | PubTator, text mining | PubMed |
| Functional Properties of Cancer Epithelium and Stroma-Derived Exosomes in Head and Neck Squamous Cell Carcinoma. | Life (Basel) | 2022 | 35629423 | PubTator, text mining | PubMed |
| Cardiorenal Syndrome: An Updated Classification Based on Clinical Hallmarks. | J Clin Med | 2022 | 35629022 | PubTator, text mining | PubMed |
| The Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 Promotes Ovarian Cancer Pathogenesis. | Int J Mol Sci | 2022 | 35628603 | PubTator, text mining | PubMed |
| Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial. | Cancers (Basel) | 2022 | 35625997 | PubTator, text mining | PubMed |
| Scratching the Surface-An Overview of the Roles of Cell Surface GRP78 in Cancer. | Biomedicines | 2022 | 35625836 | PubTator, text mining | PubMed |
| Contrasting behavior between the three human monocyte subsets in dengue pathophysiology. | iScience | 2022 | 35620424 | PubTator, text mining | PubMed |
| Emerging roles of cystathionine β-synthase in various forms of cancer. | Redox Biol | 2022 | 35618601 | PubTator, text mining | PubMed |
Effectiveness and cost-effectiveness of dynamic bracing versus standard care alone in patients suffering from osteoporotic vertebral compression fractures: protocol for a multicentre, two-armed, parallel-group randomised controlled trial with 12 months of follow-up. | BMJ Open | 2022 | 35613823 | PubTator, text mining | PubMed |
| Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung Cancer. | Mol Cancer Res | 2022 | 35612556 | PubTator, text mining | PubMed |
| Antifungal Activity of NP20 Derived from Amphioxus Midkine/Pleiotrophin Homolog Against Aspergillus niger and Aspergillus fumigatus. | Mar Biotechnol (NY) | 2022 | 35610324 | PubTator, text mining | PubMed |
| Bisphenol a exposure decreases learning ability through the suppression of mitochondrial oxidative phosphorylation in the hippocampus of male mice. | Food Chem Toxicol | 2022 | 35598803 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4192/papers?page=41